Logo of Recornea

RECORNEA SRL

Company  |
Italy, Trieste

Primary tabs

About your organization / profile

Recornea technologies prevent blindness through a proprietary technology that creates innovative nitinol based products for ophthalmic applications. The technology couples minimally invasive surgery with minimally invasive biocompatible and bioenhanced devices to treat eye conditions.

The first Recornea product, the GROSSO implant, treats keratoconus, a blindness-causing condition that deforms the cornea affecting 175 million people worldwide. In 2024, Recornea brought the GROSSO implant to the EU clinical stage at the renowned Institute of Ocular Microsurgery (IMO) in Barcelona, Spain. Additional support from 25 clinicians, 5 ophthalmic related companies and 7 investors underscore this achievement. Recornea raised €2.6M in combined non-dilutive and dilutive funding for the platform technology with 6 awarded patent and 15 patent applications, will spin out multiple innovative products such as Glaucomesh for glaucoma related ailments and U-Cornea for corneal related ailments in the coming years.

Recornea closed €1.2M of Seed Round at the end of 2024.

News

Network (0)

There are no organizations in the network.

Recent activities

Avatar

RECORNEA SRL is now a member of the EIC ACCESS+ community.

Avatar

RECORNEA SRL has taken its fundraising offline. 

Avatar

RECORNEA SRL has updated its fundraising

Avatar

RECORNEA SRL is now a member of the Access2EIC community.

Avatar

RECORNEA SRL has been awarded the European Innovation Council - Transition beneficiaries  label.

Avatar

RECORNEA SRL has published fundraising documents

Avatar

RECORNEA SRL has taken its fundraising offline. 

Avatar

Lepore Emiliano (Member, RECORNEA SRL) has published an article on RECORNEA SRL's page.

Avatar

The pitchdeck document has been updated in the dataroom.

Avatar

Lepore Emiliano (Member, RECORNEA SRL) has published an article on RECORNEA SRL's page.